Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
INmune Bio Inc
INMBCurrent price
8.58 USD
-0.11 USD (-1.27%)
Last closed
8.47 USD
Company
www.inmunebio.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
159 841 792 USD
Yield for 12 month
+2.63 %
1Y
3Y
5Y
10Y
15Y
INMB
INmune Bio, Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company's development programs include INKmune, which is in Phase 1 for the treatment of patients with high-risk myelodysplastic syndrome; and INB03, a mucinous polyglucan on the surface of some epithelial cancer cells that appears to predict resistant to immunotherapy, including women with MUC4 expressing HER2+ breast cancer and other MUC4 resistant cancers. It also provides XPro1595 for the treatment of Alzheimer's disease and treatment resistant depression. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; and University of Pittsburg. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida. Address: 225 NE Mizner Blvd., Boca Raton, FL, United States, 33432
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
19.67 USDP/E ratio
–Dividend Yield
–Current Year
+155 000 USD
Last Year
+374 000 USD
Current Quarter
+14 000 USD
Last Quarter
+28 000 USD
Current Year
+155 000 USD
Last Year
+374 000 USD
Current Quarter
+14 000 USD
Last Quarter
+28 000 USD
Key Figures INMB
1 year
3 years
5 years
10 years
EBITDA
–
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-35.53 %
PEG Ratio
–
Return On Equity TTM
-81.82 %
Wall Street Target Price
19.67 USD
Revenue TTM
131 000 USD
Book Value
1.57 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-63.2 %
Dividend Yield
–
Gross Profit TTM
374 000 USD
Earnings per share
-1.92 USD
Diluted Eps TTM
-1.92 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics INMB
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History INMB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation INMB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1044.4133
Price Sales TTM
1208.357
Enterprise Value EBITDA
-5.4431
Price Book MRQ
4.9109
Financials INMB
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators INMB
For 52 weeks
6.5 USD
14.74 USD
50 Day MA
9.01 USD
Shares Short Prior Month
1 993 750
200 Day MA
10.16 USD
Short Ratio
10.53
Shares Short
2 139 247
Short Percent
13.98 %
BeatStart